Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Bile Duct Carcinoma”

1,465 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,465 results

Not applicableStudy completedNCT02841800
What this trial is testing

Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis

Who this might be right for
Liver CancerBile Duct CancerPancreatic Cancer
National Taiwan University Hospital 5
Not applicableStudy completedNCT00579865
What this trial is testing

Quality Of Life in Patients With Malignant Biliary Obstruction

Who this might be right for
Gallbladder CancerLiver CancerBile Duct Cancer
Memorial Sloan Kettering Cancer Center 124
Testing effectiveness (Phase 2)Study completedNCT03199274
What this trial is testing

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Thomas Jefferson University 104
Not applicableLooking for participantsNCT05444478
What this trial is testing

Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMicrowave AblationLiver Cancer+2 more
Sun Yat-sen University 274
Not applicableStudy completedNCT04476082
What this trial is testing

Nutrition in Gastrointestinal Tumors

Who this might be right for
Pancreatic CancerOesophageal CancerColon Cancer+7 more
University Medicine Greifswald 66
Testing effectiveness (Phase 2)Study completedNCT02291133
What this trial is testing

Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

Who this might be right for
Liver Cancer
Masa Bosnjak 25
Not applicableStudy completedNCT01360255
What this trial is testing

AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)

Who this might be right for
Hepatocellular Carcinoma
University Hospital Freiburg 70
Early research (Phase 1)Looking for participantsNCT06326502
What this trial is testing

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaLiver Cancer
Etnova Therapeutics Corp. 50
Very early researchStudy completedNCT03407001
What this trial is testing

Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis

Who this might be right for
Cirrhosis
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT07227012
What this trial is testing

Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Who this might be right for
Carcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more
Pfizer 138
Testing effectiveness (Phase 2)UnknownNCT05603039
What this trial is testing

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Liver Cancer
Qilu Pharmaceutical Co., Ltd. 80
Not applicableLooking for participantsNCT06715839
What this trial is testing

Target-specific immunoPET Imaging of Digestive System Carcinoma

Who this might be right for
MalignancyDigestive CancerDigestive System Neoplasm+12 more
RenJi Hospital 400
Testing effectiveness (Phase 2)UnknownNCT05622136
What this trial is testing

Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
Instituto do Cancer do Estado de São Paulo 28
Large-scale testing (Phase 3)Study completedNCT01908426
What this trial is testing

Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Exelixis 707
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Not applicableNo Longer AvailableNCT00701168
What this trial is testing

Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

Who this might be right for
Carcinoma, HepatocellularNeoplasm Metastasis
Leo W. Jenkins Cancer Center
Large-scale testing (Phase 3)Study completedNCT01313377
What this trial is testing

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
UNICANCER 190
Early research (Phase 1)UnknownNCT01721941
What this trial is testing

TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Scripps Clinic Cancer Center 20
Load More Results